Pentobarbital will decrease the extent or result of artemether/lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration with strong CYP3A4 inducers may lead to lowered serum concentrations and loss of antimalarial efficacy Monitor Closely (1)pentobarbital will minimize the level or result of tofacitinib by impacting hepat... https://williame022yri6.governor-wiki.com/user